查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1133468

2022-2029 年心臟 MRI 檢查的全球市場

Global Cardiac MRI Testing Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場動態

心臟 MRI 檢查市場的增長是由心血管疾病患病率上升、老年人口增加、技術進步和研究活動推動的。

預計心血管疾病患病率上升將推動市場增長。

預計久坐生活方式的增加將在預測期內提振市場。根據世界衛生組織 (WHO) 的數據，心血管疾病 (CVD) 是全球死亡的主要原因。 2021 年 6 月的數據估計每年有 1790 萬人死亡。缺乏運動、不健康的飲食、吸煙和酒精的有害影響都是心髒病和中風的危險因素。這些危險因素與高血壓、血糖失衡、血脂失衡、超重和肥胖有關。 MRI 掃描用於識別這些高階 CVD 風險。

此外，根據 2022 年 4 月發表在《美國心髒病學會雜誌》上的一項研究，預計到 2060 年，美國心血管危險因素和疾病的發病率將顯著增加。心血管疾病趨勢的顯著增加可能會增加美國醫療保健系統的負擔，以及現在需要預防教育和公平獲得治療以預防未來的疾病。成為焦點。此外，2021 年 6 月，世衛組織發布了一份用於管理心血管疾病的優先醫療器械清單，包括用於醫學成像的 MRI，從而推動了全球心臟 MRI 市場。

其他成像選項的可用性阻礙了市場增長

但是，市場上存在的替代成像選項（例如心血管成像模式）限制了心臟 MRI 檢查市場。此外，由於醫療保健技術的進步，醫療費用呈上升趨勢。

COVID-19 影響分析

COVID-19 的出現對全球心臟 MRI 檢測市場產生了相當大的影響。 COVID-19 感染已像野火一樣在世界各地蔓延。它主要影響呼吸系統。 COVID-19 與心肌損傷有關，通常直接通過病毒感染或間接通過全身炎症和內皮激活。心臟 MRI 對診斷心肌炎患者至關重要，因此在大流行期間增加了對心臟 MRI 檢查的需求。隨著大流行中患者數量的增加，對心臟核磁共振檢查的需求也在增加。然而，在大流行期間，強制性封鎖和交通限制使進入醫療設施變得困難。另一方面，對於 COVID-19 患者，老年人面臨著缺乏心髒病診斷和常規治療的問題。它影響了心臟 MRI 檢查市場的大小市場參與者。但是，到 2022 年年中，情況已經從 COVID-19 中恢復過來。市場增長機會可能會出現。

全球心臟 MRI 檢查市場報告將提供對大約 40 多個市場數據表、45 多個數字和 200 多頁（大約）的訪問。

內容

第一章市場研究方法和範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

  • 按應用劃分的市場細分
  • 最終用戶的市場細分
  • 按地區劃分的市場細分

第 4 章市場動態

  • 市場影響因素
    • 驅動程序
      • 心血管疾病發病率上升
      • 研究活動增加
    • 約束因素
    • 其他成像選項的可用性
    • 影響分析

第五章行業分析

  • 波特五力分析
  • 供應鏈分析
  • 監管分析
  • 定價分析
  • 未滿足的需求分析

第 6 章 COVID-19 分析

  • COVID-19 的市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按應用程序

  • 影像診斷
  • 病人監護
  • 影像引導治療

第 8 章最終用戶

  • 醫院和診所
  • 心髒病診所
  • 門診手術中心
  • 診斷中心
  • 其他

第 9 章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 10 章競爭格局

  • 主要發展和戰略
  • 公司份額分析
  • 應用基準測試

第 11 章公司簡介

  • Koninklijke Philips N.V.
    • 公司概況
    • 應用組合和說明
    • 主要亮點
    • 財務摘要
  • FUJIFILM Corporation
  • Canon Inc.
  • NeoSoft LLC
  • Siemens Healthcare Private Limited
  • Pie Medical Imaging
  • Medis Medical Imaging
  • Symphony Innovation, LLC
  • Circle Cardiovascular Imaging Inc
  • GE Healthcare

第 12 章心臟 MRI 全球市場-DataM

簡介目錄
Product Code: DMCD5861

Market Overview

Cardiac MRI Testing Market Size was valued at US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of X% during the forecast period (2022-2029).

Cardiac MRI testing is a scan of a patient's heart in which radio waves and magnets build images without any side effects for the patient's body. An MRI scan is able to show parts of the heart, including chambers and valves, and how they are working. A cardiac MRI scan can diagnose heart problems such as heart failure, heart valve disease, heart muscle inflammation or infection, and other conditions.

Market Dynamics

The cardiac MRI testing market growth is driven by the rise in the prevalence of cardiovascular diseases, the increase in the geriatric population, technological advancements, and research activities.

The rising prevalence of the cardiovascular disease is expected to drive the market growth

The rising sedentary lifestyle is expected to boost the market over the forecast period. As per the World Health Organization, cardiovascular diseases (CVD) are the main cause of death worldwide. As per the June 2021 data, It is estimated that 17.9 million die each year. Physical inactivity, an unhealthy diet, tobacco use, and the harmful effects of alcohol are all risk factors for heart disease and stroke. These risk factors are associated with high blood pressure, blood glucose imbalance, blood lipid imbalance, overweight, and obesity. MRI testing is used to identify these high-level risks of CVDs.

Furthermore, in the April 2022, as per the study published report in the Journal of the American College of Cardiology, By the year 2060, it is expected that rates of cardiovascular risk factors and disease will increase significantly in the United States. Considerable increases in cardiovascular trends may contribute to an increasing burden on the U.S. health care system and spotlight the necessity for impartial access to precaution education and treatments now to prevent future disease. Moreover, in June 2021, the WHO published a list of priority medical devices for management of cardiovascular diseases, including MRI for medical imaging, which boosted the cardiac MRI market worldwide.

The availability of other imaging options will hamper the growth of the market

However, the availability of alternative imaging options such as cardiovascular imaging modalities in the market limits the cardiac MRI testing market. In addition, healthcare costs are increasing due to the advancement in healthcare technology.

COVID-19 Impact Analysis

The appearance of COVID-19 considerably impacted the global cardiac MRI testing market. COVID-19 infection spread like wildfire around the world. It primarily affects the respiratory system. COVID-19 is associated with myocardial injury, which is more common and can occur directly due to viral infection or indirectly due to systemic inflammation or endothelial activation. As cardiac MRI is important for the diagnostic process of patients with myocarditis, results in an increasing demand for cardiac MRI testing during a pandemic. As the pandemic's case count increased, so did the demand for cardiac MRI testing. However, due to the enforced lockdown and transportation restrictions, access to the health care system was difficult during the pandemic. On the Other hand, for COVID-19 patients, the elderly population faces a lack of diagnosis and regular treatment for heart disease. It has an impact on the large and small market players in the cardiac MRI testing market. But, in the middle of 2022, the situation is recovering from COVID-19. There will be an opportunity for market growth.

Segment Analysis

The patient monitoring segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The patient monitoring segment is expected to boost the market over the period of the forecast. This is owing to the increased prevalence of cardiovascular disease, a rise in the geriatric population, and health issues occurring in the COVID-19 pandemic, which results in an increasing demand for monitoring of patients to diagnose the diseases. Cardiac MRI is an accurate and effective solution for monitoring the heart health of patients with different diseases such as arrhythmias, abnormal heartbeats, and heart failure.

According to Census Bureau estimations, by 2030, the number of people aged 65 and older in the United States will increase faster than the young population (aged 18 and under). The older population suffers from a greater degree of health issues than the younger population, resulting in shifting demand for monitoring solutions to diagnose, track and treat health issues such as cardiovascular disease.

Geographical Analysis

North American region holds the largest market share of the global Cardiac MRI testing market

North America dominates the market for cardiac MRI testing and is expected to show a similar trend over the forecast period. It is estimated to hold a significant market size over the forecast period (2022-2029) owing to advancements in healthcare infrastructure and the availability of diagnostic imaging systems for heart disease. According to the centers of disease control and prevention, heart disease is the leading cause of death in people in different age groups in the United States region. One person dies every 34 seconds because of cardiac disease.

In 2020, around 697,000 people in the United States die from heart disease. In the population with Cardiac Artery Disease (CAD), about 20.1 million adults age 20 and older have CAD (about 7.2%). In the United States, 805,000 have heart attacks every year. As the population with CVD increases in the North American region, the demand to diagnose the disease results in an increasing demand for MRI testing in the region. Technological advancements boost the market growth in the North American region. For instance, in September 2022, University of Minnesota Twin Cities scientists and their team found a solution to upgrade the performance of traditional (MRI) reconstruction techniques, enabling faster MRIs to improve healthcare.

Competitive Landscape

The cardiac MRI testing market is a moderately competitive presence of local as well as global companies. Some of the key players which are contributing to the growth of the market are Koninklijke Philips N.V, FUJIFILM Corporation, Canon Inc., NeoSoft LLC, Siemens Healthcare Private Limited, Pie Medical Imaging, Medis Medical Imaging, Symphony Innovation, LLC, Circle Cardiovascular Imaging Inc., and GE Healthcare among others. The major players are adopting several growth strategies such as new product launches, acquisitions, and collaborations, which are contributing to the growth of the cardiac MRI testing market globally.

For instance,

  • In February 2022, GE Healthcare received approval from the European Medicines Agency (EMA) for additional imaging modalities for its stress agent Rapiscan (Regadenoson). Rapiscan is approved for use in Magnetic Resonance Imaging (MRI) as well as Computed Tomography (CT) and Positron Emission Tomography (PET).

Canon Medical Systems Corporation

Overview:

Canon Medical Systems Corporation is a Japanese multinational corporation headquartered in Tokyo, Japan. The company offers a broad range of diagnostic medical imaging solutions, including CT, MR, X-Ray, ultrasound, and healthcare informatics, across the globe. It offers imaging solutions for ischemic heart disease, structural heart disease, and congenital heart disease.

Product Portfolio:

k-t SPEEDER: This MR imaging technology provides up to 8x faster frame rate cardiac cine and perfusion with free breathing. It is easy to use for patients and offers images a wide range of heart patients. In addition, it also helps to acquire high temporal resolution cardiac cine without compromising patient comfort.

The global cardiac MRI testing market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

Table of Contents

1. Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet By Application
  • 3.2. Market snippet By End User
  • 3.3. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The rising incidences of cardiovascular diseases
      • 4.1.1.2. The increasing number of research activities
    • 4.1.2. Restraints:
    • 4.1.3. Availability of other imaging options
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis
  • 5.4. Pricing Analysis
  • 5.5. Unmet Needs

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
    • 7.1.2. Market Attractiveness Index, By Application Segment
  • 7.2. Diagnostic Imaging*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Patient Monitoring
  • 7.4. Image Guided Treatment

8. By End User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 8.1.2. Market Attractiveness Index, By End User
  • 8.2. Hospitals and Clinics*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Cardiovascular Clinics
  • 8.4. Ambulatory Surgical Centers
  • 8.5. Diagnostics Centres
  • 8.6. Others

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.2.5.1. The U.S.
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.3.5.1. Germany
      • 9.3.5.2. U.K.
      • 9.3.5.3. France
      • 9.3.5.4. Italy
      • 9.3.5.5. Spain
      • 9.3.5.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.4.5.1. Brazil
      • 9.4.5.2. Argentina
      • 9.4.5.3. Rest of South America
  • 9.5. Asia Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.5.5.1. China
      • 9.5.5.2. India
      • 9.5.5.3. Japan
      • 9.5.5.4. Australia
      • 9.5.5.5. Rest of Asia Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

  • 10.1. Key Developments and Strategies
  • 10.2. Company Share Analysis
  • 10.3. Application Benchmarking

11. Company Profiles

  • 11.1. Koninklijke Philips N.V.*
    • 11.1.1. Company Overview
    • 11.1.2. Application Portfolio and Description
    • 11.1.3. Key Highlights
    • 11.1.4. Financial Overview
  • 11.2. FUJIFILM Corporation
  • 11.3. Canon Inc.
  • 11.4. NeoSoft LLC
  • 11.5. Siemens Healthcare Private Limited
  • 11.6. Pie Medical Imaging
  • 11.7. Medis Medical Imaging
  • 11.8. Symphony Innovation, LLC
  • 11.9. Circle Cardiovascular Imaging Inc
  • 11.10. GE Healthcare

LIST NOT EXHAUSTIVE

12. Global Cardiac MRI Testing Market- DataM

  • 12.1. Appendix
  • 12.2. About Us and Services
  • 12.3. Contact Us